PLAY PODCASTS
Advances in the diagnosis of heparin-induced thrombocytopenia
Episode 24

Advances in the diagnosis of heparin-induced thrombocytopenia

In this episode, Anand Padmanabhan, M.B.B.S., Ph.D., a physician-scientist and consultant in the divisions of Hematopathology, Transfusion Medicine, and Experimental Pathology at Mayo Clinic, discusses new ways to detect heparin-induced thrombocytopenia a

Lab Medicine Rounds · Mayo Clinic Laboratories

November 13, 202016m 16s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Timestamps:

00:00 Intro

01:00 What is HIT and why is it important for clinicians to correctly diagnose HIT? 

03:30 What do we know about how laboratory testing may help clinicians get the diagnosis right?

 

07:25 How could the process of diagnosing HIT be updated or made better?

10:45 What does the future hold for HIT testing? In five years’ time what do you think HIT testing is going to look like in this country?

12:45 How has your relationship with your clinical colleagues helped advance your practice of medicine? 

15:30 Outro

Related Resources:

Conference: A Case-Based Workshop: Clinical and Laboratory Aspects of Hemophilia and Thrombosis

Article: National Symposium Focuses on Bleeding and Thrombotic Disorders

Topics

heparin-induced thrombocytopeniahematologyhematopathologycoagulationlaboratory medicinehealth careMayo Clinic Laboratories